Tuesday 9 October
10 October
Presentation Keynote Chair Plenary Keynote Forum /
Workshop
Exhibitor
[Schedule with Sessions only]
DAY 1Platinum Suite 1Platinum Suite 2Platinum Suite 3Platinum Suite 4Platinum Suite 5Platinum Suite 6Platinum Suite 7Career ZoneTraining Zone
DAY 2
DAY 1Platinum Suite 1Platinum Suite 2Platinum Suite 3Platinum Suite 4Platinum Suite 5Platinum Suite 6Platinum Suite 7Career ZoneTraining Zone
DAY 2
08:00 Conference Registration 08:00
08:05 08:05
08:10 08:10
08:15 08:15
08:20 CamBioScience hands-on training courses overview
08:20 (25 mins)
Find out about the various topics, locations, and instructors. You can join the priority list for our future editions and suggest new topics via our online form accessible from your wifi device on the...[More]
08:20
08:25 08:25
08:30 08:30
08:35 Innovations in biochemical and biophysical hit finding techniques
Chairs: Miss Cara Hall, Bio-Rad 
08:35
08:40 08:40
08:45 ELRIG Annual Review
08:45 (15 mins)
Steve Rees - ELRIG Chairman
Come chat to us
08:45 (90 mins)
We will discuss your training requirements, share resources, and you can join the priority lists for any of our future courses. Have an idea for a particular training course, just come to the training...[More]
08:45
08:50 08:50
08:55 08:55
09:00 Conference & Plenary Keynote Introduction
09:00 (15 mins)
Rachel Grimley- AstraZeneca
09:00
09:05 09:05
09:10 09:10
09:15 Plenary Keynote - Day 1
Drug repurposing for ageing research
09:15 (45 mins)
Prof Janet Thornton, European Bioinformatics Institute 
09:15
09:20 09:20
09:25 09:25
09:30 09:30
09:35 09:35
09:40 09:40
09:45 09:45
09:50 09:50
09:55 09:55
10:00 10:00
10:05 10:05
10:10 10:10
10:15 Coffee How to create and take personalised training courses online thanks to Artificial Intelligence
10:15 (35 mins)
10:15
10:20 10:20
10:25 10:25
10:30 10:30
10:35 10:35
10:40 10:40
10:45 Sartorius Stedim Biotech Workshop Live-cell analysis techniques: developing translational assays for drug discovery
10:45 (5 mins)
Translational assays provide critical bridges between in vitro models and the clinic, enabling a greater understanding of disease and potential therapy. To meet these requirements has resulted in an ...[More]
10:45
10:50 Session Chair Introductions
10:50 (10 mins)
Martin Swarbrick (CRUK TDL) & Nicole Hamblin (Charles River)
Session Chair Introductions
10:50 (10 mins)
Eddy Stevens (Ario Pharma) & Mark Slack (Evotec)
Session Chair Introductions
10:50 (10 mins)
David Brown (Healx Ltd) & Chris Dowson (Warwick University)
Session Chair Introductions
10:50 (10 mins)
Sarah Nickolls (GSK) & David Kendall (Pharmnovo)
Welcome & introductions
10:50 (5 mins)
Tim Dale - Sartorius
Biohub - " Building Biotech Success: A Practical Case Study with CROs at Alderley Park"
10:50 (70 mins)
Presenting: • Blueberry Therapeutics - Dave Cook • Apconix - Ruth Roberts • Aptus Clinical - Steve McConchie • Alderley Park Accelerator (BioHub) - Ned Wakeman
Short live introduction to Organoid technology.
10:50 (100 mins)
Digital lecture on “Cerebral Organoids” on our AI-Learning platform OBRIZUM®, by world-leading expert in the field, Dr Madeline Lancaster (University of Cambridge) - followed by “Check your knowledge”...[More]
10:50
10:55 Kinetic measurements of immune cell cytotoxicity
10:55 (25 mins)
Dan Foxler - GammaDelta Therapeutics
10:55
11:00 Chemistry Innovations
Highly potent and selective tumour targeting bicyclic peptides - a novel approach to cancer therapy
11:00 (30 mins)
Gemma Mudd, Bicycle Therapeutics 
Innovations in cellular HTS and compound profiling
Using Single Cell Sequencing for Drug discovery
11:00 (30 mins)
Prof Martin Guilliams, VIB institute for inflammation 
Anti-infectives & Rare Diseases
Using AI to accelerate combinations drug discovery for rare diseases
11:00 (30 mins)
Michale Bouskila-Chubb, Healx Ltd 
BPS Session
Ligand bias at opioid receptors - what is it good for?
11:00 (30 mins)
Prof Eamonn  Kelly, University of Bristol 

Neuro-immune interactions and novel targets for chronic pain
11:30 (30 mins)
Prof Marzia Malcangio, Kings College London 

Targeting the reward system in addiction – structure-based drug design of selective orexin 1 receptor antagonist
12:00 (30 mins)
Dr Kirstie Bennett, Heptares Therapeutics  
11:00
11:05 11:05
11:10 11:10
11:15 11:15
11:20 Live cell imaging assays for Immuno-oncology drug screening
11:20 (25 mins)
Jessy Cartier - Aquila BioMedical
11:20
11:25 11:25
11:30 Poster Spotlight - Poster 45 - Thomas Christott
11:30 (15 mins)
Development of a chemical probe for the YEATS domains of MLLT1 and MLLT3
Poster Spotlight - Poster 55 - Rasel Al-Amin
11:30 (15 mins)
Target Engagement-Mediated Amplification for Monitoring Drug-Target Interactions in Situ
Poster Spotlight - Poster 62 - Dr Clio Andreae
11:30 (15 mins)
Tracking bacterial infection and treatment in Galleria mellonella using luminescent bacterium
PAA Workshop -Harmony, Overlord and the S-LAB automated plate handler - a powerful combination
11:30 (60 mins)
Harmony™ is an easy to use, configurable user interface that allows the control of a small or large system. S-LAB™ is a small footprint, reliable plate handler that supplies microplates from a stack,...[More]
11:30
11:35 11:35
11:40 11:40
11:45 Chemistry Innovations
How the chemical design and synthesis of linkers used in antibody drug conjugates drives the success of ADC drug development.
11:45 (30 mins)
Mark Frigerio , Abzena 
Innovations in cellular HTS and compound profiling
Cellular thermal shift assays in high throughput: a 1536-well cellular target engagement assay for drug discovery
11:45 (30 mins)
Lorena Kallal, GlaxoSmithKline 
Anti-infectives & Rare Diseases
Economic models to incentivise antibacterial drug R&D
11:45 (30 mins)
Ursula Theuretzbacher, Center for Anti-infective Agents 
New IncuCyte applications: Multi-spheroids and Cell-by-Cell analysis
11:45 (25 mins)
Tim Dale - Sartorius
11:45
11:50 11:50
11:55 11:55
12:00 12:00
12:05 12:05
12:10 Concluding remarks
12:10 (5 mins)
12:10
12:15 Merck
Innovative Tools in Medicinal Chemistry and Retrosynthetic Pathway Design by Merck. PRESENTER - Hugo Viana ABSTRACT - Sigma-Aldrich, now part of MERCK, is the market leader in Chemical Synthesis, by p...[More]
Pelago Bioscience AB
Why CETSA®HT will Accelerate your Drug Discovery Program PRESENTER - Michael Dabrowski
Labcyte Inc.
Combining Echo Liquid Handler with high-resolution imaging for exploiting host-directed immunomodulatory therapies PRESENTER - Aurore Lejeune-Dodge ABSTRACT - A promising approach to halt the increas...[More]
12:15
12:20 Eurofins Pharma Discovery Services
Eurofins Pharma Discovery Services – a Contract Innovation Organisation PRESENTER - Dr Carol Austin, Associate Director Discovery, Eurofins Selcia ABSTRACT - Selcia is a leading provider of contract r...[More]
LGC - ATCC
Physiologically relevant models to support the development and evaluation of high-throughput screening assays PRESENTER - Dr Nirmal Perera
Cisbio
HTRF Assays + Reagents for anti-infectives + Rare Diseases Research PRESENTER - Louise Affleck, PhD ABSTRACT - Cisbio has developed easy to use, robust + reliable HTRF assays for anti-infectives + Rar...[More]
12:20
12:25 I&L Biosystems UK LTD
Surface Plasmon Resonance Microscopy for Cell Membrane Proteins PRESENTER - Dr Michael Palmowski ABSTRACT - Surface Plasmon Resonance (SPR) is a widely used label-free detection technique for studying...[More]
INTEGRA Bioscience Ltd
Assist Plus PRESENTER - Sharon Barnard ABSTRACT - INTEGRA has developed the ASSIST PLUS pipetting robot to streamline routine pipetting tasks at an affordable price. Using INTEGRA electronic fixed and...[More]
Bio-Rad
Measuring genome editing efficiency using droplet digital PCR PRESENTER - Steve Elliston ABSTRACT - CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and its associated endonuclease C...[More]
12:25
12:30 Lunch & Poster Sessions CamBioScience hands-on training courses overview:
12:30 (90 mins)
Find out about the various topics, locations, and instructors. You can join the priority list for our future editions and suggest new topics via our online form accessible from your wifi device on the...[More]
12:30
12:35 12:35
12:40 12:40
12:45 12:45
12:50 12:50
12:55 12:55
13:00 13:00
13:05 13:05
13:10 13:10
13:15 Are We Nearly There Yet? Past Present and Future of Sample Management
13:15 (60 mins)
Tecan and Titian will be presenting their long standing partnership in software integration combining sample management and laboratory automation. This builds on the historical work to allow Mosaic ...[More]
13:15
13:20 13:20
13:25 13:25
13:30 13:30
13:35 13:35
13:40 13:40
13:45 13:45
13:50 13:50
13:55 SiLA Workshop - Closing the loop in the Lab using Artificial Intelligence
13:55 (5 mins)
Artificial Intelligence (AI) tools are starting to become established in pharmaceutical research and life sciences more generally - with some 69% of companies in the sector using AI and related te...[More]
13:55
14:00 Chemistry Innovations
Discovery of AZD4573, a potent and selective inhibitor of CDK9 that enables transient target engagement for the treatment of haematological malignancies.
14:00 (30 mins)
Bernard Barlaam, AstraZeneca 
Innovations in cellular HTS and compound profiling
Efficiently identifying and characterizing HTS hits with imaging biosignatures
14:00 (30 mins)
Steffen Jaensch, Janssen Pharmaceutica 
Anti-infectives & Rare Diseases
An academic entrepreneur’s thoughts about drug discovery where reductionism bumps up against biological complexity and drug promiscuity: generating meaningful targets for intractable disease conditions.
14:00 (30 mins)
Steven Zimmer, MitoDys Therapeutics 
BPS Session
Current progress and future opportunities in the development of Nav1.7 blockers for the treatment of pain
14:00 (30 mins)
Dr Zahid Ali, Mundipharma Research and Development  

Natural and engineered genetics for new pain target discovery.
14:30 (30 mins)
Dr Alex Gutteridge, GSK 

Mechanisms based approaches to novel analgesic development: what are the alternatives to opioids for chronic pain?
15:00 (30 mins)
Prof Victoria Chapman, University of Nottingham 
Medicinal Chemistry/new small Molecules
14:00 (10 mins)
Introduction and scene setting Patrick Courtney (Director, SiLA)
EARLY CAREER PROFESSIONALS Careers in Drug Discovery: Where to next?
14:00 (60 mins)
Are you a post-doc, postgraduate, early career researcher or professional (ECP) scientist looking to start or build your career in drug discovery? If so, understanding the wide array of opportunities ...[More]
Short live introduction to CRISPR genome editing
14:00 (90 mins)
- Digital lecture on “CRISPR Design & Strategy” on our AI-Learning platform OBRIZUM®, by world-leading experts Dr Oliver Baker (King’s College London) and Dr Ben Davies (University of Oxford) - follow...[More]
14:00
14:05 14:05
14:10 Activity-directed synthesis: a platform for bioactive molecular discovery Adam Nelson (Rosalind Franklin Institute/Leeds University)
14:10 (20 mins)
14:10
14:15 14:15
14:20 14:20
14:25 14:25
14:30 Poster Spotlight - Poster 69 - Linos Lazarides
14:30 (15 mins)
The Discovery of a Potent and Orally Bioavailable Macrocyclic Cyclophilin Inhibitor Based on the Structural Simplification of Sanglifherin A
Formulatrix, Inc.
Reaction Miniaturisation with Mantis and Tempest Patented Microdiaphragm Dispensers PRESENTER - Peter Djali ABSTRACT Dispensing low volumes with high accuracy and minimal dead volume is essential for ...[More]
Poster Spotlight - Poster 68 - Dr Artur Yakimovich
14:30 (15 mins)
DeepInfectome: Convolutional Neural Network Approach to Systems Biology Dataset Rediscovery
Accelerating drug discovery through automation Garry Pairaudeau (AstraZeneca)
14:30 (20 mins)
14:30
14:35 Poster Spotlight - Poster 48 - Bomi Jung
14:35 (10 mins)
High density assessment of drug distribution profiles in cultured cells
14:35
14:40 14:40
14:45 Chemistry Innovations
Biocatalysis in Drug Discovery
14:45 (30 mins)
Doru Roiban, GlaxoSmithKline 
Innovations in cellular HTS and compound profiling
Implementation of a patient derived disease model using human iPSC for drug screening
14:45 (30 mins)
Magda Bictash, UCL 
Anti-infectives & Rare Diseases
The case for combination antimicrobial chemotherapy for AMR
14:45 (30 mins)
Prof William Hope, University of Liverpool 
14:45
14:50 ROAR: The Centre for Rapid Online Analysis of Reactions Mimi Hii (Imperial College/ROAR)
14:50 (20 mins)
14:50
14:55 14:55
15:00 15:00
15:05 15:05
15:10 Discussion
15:10 (20 mins)
15:10
15:15 Malvern Panalytical Ltd
PRESENTER - Maria Walton
Beckman Coulter GmbH
We are programmed just to do, anything you want us to. PRESENTER - Dr. Ewan Grant, Sales Manager Life Science Automation and Genomics, Northern Europe, Beckman Coulter UK Ltd ABSTRACT - Although hardw...[More]
Horizon Discovery
Horizon’s cellular HTS platform for the identification of beneficial combinations in rare disease PRESENTER - David Sorrell, PhD; HTS Platform Lead ABSTRACT -Horizon is a provider of cellular HTS serv...[More]
15:15
15:20 Tecan UK Ltd
One size does not fit all PRESENTER - Guido Cimoli ABSTRACT - When it comes to laboratory automation a very common understanding is that all what is needed is a “robot” performing some tasks instead o...[More]
Hamilton
A fully automated QC workflow for therapeutic proteins PRESENTER - Dr. Carsten Mang ABSTRACT The numbers of therapeutic protein projects are increasing year by year. This requires increased efficiency...[More]
BioIVT
Vaccine Efficacy studies PRESENTER - Amanda J Woodrooffe, PhD ABSTRACT - Vaccines are the most cost-effective medical intervention for viral, bacterial, and parasitic infections, saving millions of li...[More]
15:20
15:25 Aptamer Group Limited
OptimersTM: the next step in aptamer development PRESENTER - Dr David Bunka ABSTRACT - - At Aptamer Group, we are dedicated to continually improving our service offering, to identify the best performi...[More]
Promega UK Ltd
New bioluminescent tools and approaches for physiologically relevant cellular HTS assays. PRESENTER - Dr Craig Malcolm. ABSTRACT -Robust assay tools and approaches are essential for the successful exe...[More]
LGC - ATCC
15:25
15:30 Coffee How to create and take personalised training courses online thanks to Artificial Intelligence
15:30 (30 mins)
15:30
15:35 15:35
15:40 15:40
15:45 15:45
15:50 15:50
15:55 15:55
16:00 Chemistry Innovations
Capture Compound® Mass Spectrometry: On- and Off-Target Deconvolution
16:00 (30 mins)
Andrew Cridland, Charles River 

Using PROTACs as probes to study intracellular target engagement against proteins with unknown function
16:30 (30 mins)
Matthew Cheeseman, The Institute of Cancer Research 
Innovations in cellular HTS and compound profiling
Organoids: Predicting clinical responses in an in vitro model
16:00 (30 mins)
Robert Vries, Hubrecht Organoid Technology 

Biomicrofabrication of Cellular Interfaces and Models
16:30 (30 mins)
Cristina Bertulli, University of Cambridge 
Anti-infectives & Rare Diseases
Multi-targeting to reduce bacteria resistance
16:00 (30 mins)
Prof Chris Dowson, University of Warwick 

Combination drugs for safe treatment of children with rare cancers
16:30 (30 mins)
Dr David Brown, Healx Ltd 
BPS Session
Delta opioid receptor agonists; potential in chronic pain therapy
16:00 (30 mins)
David Kendall, PharmNovo AB/UK 

Altered pain processing in a rat model of negative affective state: a role for the endogenous cannabinoid and opioid systems
16:30 (30 mins)
Prof David Finn, NUI Galway  
Screening - Adalab closed loop and underpinning ontologies Larisa Soldatova (Goldsmiths College/ ADALab)
16:00 (20 mins)
Short live introduction to Organoid technology
16:00 (60 mins)
- Digital lecture on “Cerebral Organoids” on our AI-Learning platform OBRIZUM®, by world-leading expert in the field, Dr Madeline Lancaster (University of Cambridge) - followed by “Check your knowledg...[More]
16:00
16:05 16:05
16:10 16:10
16:15 16:15
16:20 Smarter screening, how to leverage AI to ‘close the loop’ Kevin Teburi, Genedata
16:20 (20 mins)
16:20
16:25 16:25
16:30 16:30
16:35 16:35
16:40 Lundbeck’s transition to integrated drug discovery informatics platform Plamen Petrov (Lundbeck Pharma)
16:40 (20 mins)
16:40
16:45 16:45
16:50 16:50
16:55 16:55
17:00 Drinks reception & Posters Enabling ML and AI through a Standards-based Data Pipeline Burkhard Schaefer, (BSSN Software / SiLA Board of Directors)
17:00 (30 mins)
End of workshop
Come chat to us:
17:00 (90 mins)
We will discuss your training requirements, share resources, and you can join the priority lists for any of our future courses. Have an idea for a particular training course, just come to the training...[More]
17:00
17:05 17:05
17:10 17:10
17:15 EARLY CAREER PROFESSIONALS Careers in Drug Discovery: Network like a Boss
17:15 (60 mins)
Are you a post-doc, postgraduate, early career researcher or professional (ECP) scientist looking to start or build your career in drug discovery? If so, building and managing your network of contacts...[More]
17:15
17:20 17:20
17:25 17:25
17:30 17:30
17:35 17:35
17:40 17:40
17:45 17:45
17:50 17:50
17:55 17:55
18:00 18:00
18:05 18:05
18:10 18:10
18:15 18:15
18:20 18:20
18:25 18:25
18:30 18:30
18:35 18:35
18:40 18:40
18:45 18:45
18:50 18:50
18:55 18:55
19:00 19:00